About Marisa de la Cruz
This author has not written his bio yet.
But we are proud to say that Marisa de la Cruz contributed 87 entries already.
Entries by Marisa de la Cruz
$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease
October 31, 2019 Click here to read the full article. Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.
New Bay Area Spin-Off Company to Develop Drugs for Multiple Sclerosis and Alzheimer’s Disease
October 8, 2019 Click here to read full article. Gladstone team of (from left) Jae Kyu Ryu, Anke Meyer-Franke, Katerina Akassoglou, and Stephen Freedman worked with entrepreneur Edward Spack to launch MedaRed, Inc.
Momentum, NMSS Magazine – A big part of the MS puzzle
July 11, 2019 Click here to view article.
Meet Gladstone: Andrew Mendiola
June 21, 2019 Andrew is a postdoctoral scholar in Katerina Akassoglou’s lab. He grew up in Marion, Texas, a small town in-between Austin and San Antonio. Before joining Gladstone, he completed a PhD in cellular and molecular biology with a concentration in immunology at The University of Texas at San Antonio. Click here to read […]
MS News Today – Need to Know: What Is the Blood Brain Barrier?
June 13, 2019 Click here to read full article.
Andrew Mendiola Receives a Best Poster Award at the Gladstone Institutes Scientific Retreat 2019
May 22, 2019 Congratulations to Andrew Mendiola in our lab, and all others, for receiving Best Poster Awards at the Gladstone Institutes Scientific Retreat 2019!
Fibrinogen Immunohistochemistry – Mouse
Davalos D, Ryu JK, Merlini M, Baeten KM, Le Moan N, Petersen MA, Deerinck TJ, Smirnoff DS, Bedard C, Hakozaki H, Gonias Murray S, Ling JB, Lassmann H, Degen JL, Ellisman MH, Akassoglou K. Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat Commun. 2012; 3:1227.